Total Funding
82
61
Total FundingPost-IPO Debt raised
Growth Score 82 in past quarter
-7 pts
Heat Score 61 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
217102
Bioxyne is a Health/beauty.
- Samuel Watson: Managing Director and Founder
About the Company
ioxyne is one of the few companies that own a patented and clinically tested probiotic. Their probiotic product range contains their patented strain PCC® (Lactobacillus fermentum VRI-003). PCC® has a superior ability to survive in the acid environment of the stomach and to colonise the intestinal tract. The effectiveness of PCC® to boost immune and
gastrointestinal health has been demonstrated in several clinical trials. PCC® and their probiotic products are manufactured by Chr. Hansen, a global leader in the manufacturing of probiotics and other dietary supplement products for the food, health, pharmaceutical and agricultural businesses.